Aberdeen, United Kingdom

Serena Deiana

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wista Laboratories Ltd.. Active years: 2015.


% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Serena Deiana

Introduction

Serena Deiana is a notable inventor based in Aberdeen, GB. She has made significant strides in the field of cognitive health through her innovative research and development. Her work primarily focuses on the treatment of Mild Cognitive Impairment (MCI), showcasing her commitment to improving mental health outcomes.

Latest Patents

Serena holds a patent for "Phenothiazine compounds for treating mild cognitive impairment." This invention relates to methods and materials based on diaminophenothiazines, which are utilized in the treatment of MCI. Her patent represents a crucial advancement in addressing cognitive health issues.

Career Highlights

Throughout her career, Serena has demonstrated a strong dedication to research and innovation. She is currently associated with Wista Laboratories Ltd., where she continues to explore new avenues for improving cognitive health. Her work has garnered attention for its potential impact on the treatment of cognitive impairments.

Collaborations

Serena has collaborated with esteemed colleagues, including Claude Michel Wischik and Dominic Venay Harbaran. These partnerships have enriched her research and contributed to the development of her innovative solutions.

Conclusion

Serena Deiana's contributions to the field of cognitive health through her patent and collaborative efforts highlight her role as a leading inventor. Her work is paving the way for advancements in the treatment of Mild Cognitive Impairment, making a significant impact on mental health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…